Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy
Avani R. Vyas(University of Pittsburgh Medical Center), Umamaheswar Duvvuri(City University of New York), Jonathan Pacheco(Universidad Nacional Autónoma de México), Andrew G. Sikora(Baylor College of Medicine), Devraj Basu(University of Pennsylvania), Silvia Cruz‐Rangel(University of Pittsburgh), Roberto Gomez-Casal(UPMC Hillman Cancer Center), Kirill Kiselyov(University of Pittsburgh), Hugo Villanueva(Baylor College of Medicine), Pavithra Rajagopalan(Institute of Bioinformatics), Gerald Hammond(University of Pittsburgh)
Cited by 37
Related Papers
A draft map of the human proteome
|Nature|2014|2.3k
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
|Cancer Discovery|2013|590